Search Within

Kevin Joseph Curran

  1. "Weinberg Fellows"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. GSK Faculty (9)
  4. Hematologic Malignancies, Division of (9)
  5. Pediatrics, Department of (9)
  6. Stem Cell Transplantation and Cellular Therapy Service (9)

More Groups

People
  1. Isabelle Riviere (5)
  2. Jae Park (5)
  3. Renier Brentjens (5)
  4. Sergio Giralt (5)
  5. Xiuyan Wang (5)
  6. Brigitte Senechal (4)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Blood (4)
  2. Blood Advances (1)
  3. Cancer Cell (1)
  4. Journal of Clinical Investigation (1)
  5. Journal of Molecular Diagnostics (1)
  6. Molecular Therapy - Methods & Clinical Development (1)
Publishers
  1. American Society of Hematology (5)
  2. American Society for Clinical Investigation (1)
  3. Cell Press (1)
  4. Elsevier Science, Inc. (1)
  5. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology
    Journal Article

    Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CD40 ligand-modified chimeric antigen receptor T cells enhance antitumor function by eliciting an endogenous antitumor response
    Journal Article

    Kuhn, N. F.; Purdon, T. J.; van Leeuwen, D. G.; Lopez, A. V.; Curran, K. J.; Daniyan, A. F.; Brentjens, R. J.
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save